UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 14.

Wiestler, B; Capper, D; Hovestadt, V; Sill, M; Jones, D T W; Hartmann, C; Felsberg, J; Platten, M; Feiden, W; Keyvani, K; Pfister, S M; Wiestler, O D; Meyermann, R; Reifenberger, G; Pietsch, T; von Deimling, A; Weller, M; Wick, W (2014). Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Neuro-Oncology, 16(12):1630-1638.

Goeppert, B; Schmidt, C R; Geiselhart, L; Dutruel, C; Capper, D; Renner, M; Vogel, M N; Zachskorn, C; Zinke, J; Campos, B; Schmezer, P; Popanda, O; Wick, W; Weller, M; Meyermann, R; Schittenhelm, J; Harter, P N; Simon, P; Weichert, W; Schirmacher, P; Plass, C; Mittelbronn, M (2013). Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation. Journal of Neuropathology and Experimental Neurology, 72(10):933-941.

Mittelbronn, M; Warth, A; Meyermann, R; Goodman, S; Weller, M (2013). Expression of integrins αvβ3 and αvβ5 and their ligands in primary and secondary central nervous system neoplasms. Histology and Histopathology, 28(6):749-758.

Schittenhelm, J; Simon, P; Harter, P N; Zachskorn, C; Schlaszus, H; Röttger, F; Winkels, M; Weller, M; Meyermann, R; Mittelbronn, M (2011). CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms. Histopathology, 58(5):739-749.

Weiler, M; Hartmann, C; Wiewrodt, D; Herrlinger, U; Gorlia, T; Bähr, O; Meyermann, R; Bamberg, M; Tatagiba, M; von Deimling, A; Weller, M; Wick, W (2010). Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide. International Journal of Radiation Oncology, Biology and Physics, 77(3):670-676.

Hartmann, C; Hentschel, B; Wick, W; Capper, D; Felsberg, J; Simon, M; Westphal, M; Schackert, G; Meyermann, R; Pietsch, T; Reifenberger, G; Weller, M; Loeffler, M; von Deimling, A (2010). Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathologica, 120(6):707-718.

Wick, W; Hartmann, C; Engel, C; Stoffels, M; Felsberg, J; Stockhammer, F; Sabel, M C; Koeppen, S; Ketter, R; Meyermann, R; Rapp, M; Meisner, C; Kortmann, R D; Pietsch, T; Wiestler, O D; Ernemann, U; Bamberg, M; Reifenberger, G; von Deimling, A; Weller, M (2009). NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide. Journal of Clinical Oncology, 27(32):5874-5880.

Mittelbronn, M; Harter, P; Warth, A; Lupescu, A; Schilbach, K; Vollmann, H; Capper, D; Frei, K; Bertalanffy, H; Weller, M; Meyermann, R; Lang, F; Simon, P (2009). EGR-1 is regulated by N-methyl-D-aspartate-receptor stimulation and associated with patient survival in human high grade astrocytomas. Brain Pathology, 19(2):195-204.

Schittenhelm, J; Beschorner, R; Simon, P; Tabatabai, G; Herrmann, C; Schlaszus, H; Capper, D; Weller, M; Meyermann, R; Mittelbronn, M (2009). Diagnostic value of WT1 in neuroepithelial tumours. Neuropathology and Applied Neurobiology, 35(1):69-81.

Tritschler, I; Gramatzki, D; Capper, D; Mittelbronn, M; Meyermann, R; Saharinen, J; Wick, W; Keski-Oja, J; Weller, M (2009). Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells. International Journal of Cancer, 125(3):530-540.

Schittenhelm, J; Reifenberger, G; Ritz, R; Nägele, T; Weller, M; Pantazis, G; Capper, D; Beschorner, R; Meyermann, R; Mittelbronn, M (2008). Primary anaplastic ganglioglioma with a small-cell glioblastoma component. Clinical Neuropathology, 27(2):91-95.

Mittelbronn, M; Capper, D; Bader, B; Schittenhelm, J; Haybaeck, J; Weber, P; Meyermann, R; Kretzschmar, H A; Wietholter, H (2008). Severe hypoxia and multiple infarctions resembling Creutzfeldt-Jakob disease. Folia Neuropathologica, 46(2):149-153.

Wiendl, H; Feger, U; Mittelbronn, M; Jack, C; Schreiner, B; Stadelmann, C; Antel, J; Brueck, W; Meyermann, R; Bar-Or, A; Kieseier, B C; Weller, M (2005). Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain: A Journal of Neurology, 128(Pt 11):2689-2704.

Wintterle, S; Schreiner, B; Mitsdoerffer, M; Schneider, D; Chen, L; Meyermann, R; Weller, M; Wiendl, H (2003). Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Research, 63(21):7462-7467.

This list was generated on Sat Jul 22 02:03:30 2017 CEST.